Back to IDIX Stock Lookup

IDIX Related FDA

Mar 22, 2013 04:15 PM Idenix Pharma (IDIX) Receives Adverse Decision in HCV Patent Filing; Will Appeal

Feb 4, 2013 04:10 PM Idenix Pharma (IDIX) to Cease IDX184, IDX19368 Programs

Jan 28, 2013 07:01 AM Idenix (IDIX) Enters Collaboration with Janssen Pharma for DAA HCV Evaluatlion

Nov 12, 2012 07:54 AM Idenix Pharmaceuticals (IDIX) Reports Clinical Data For HCV Drugs

Sep 20, 2012 08:17 AM Idenix (IDIX) Updates Investor Presentation Related to IDX184 Partial Clinical Hold and Additional Data Requests

Aug 28, 2012 03:42 PM Barclays on U.S. Biopharmaceuticals: Fate of Nucs Under Harsh Scrutiny - More Angst for IDIX; GILD Widens Lead

Aug 27, 2012 08:56 AM Idenix Pharma (IDIX) Peers on Watch as FDA Places Clinical Hold on Another HCV Treatment (ACHN) (GILD)

Aug 27, 2012 08:31 AM Idenix Pharma (IDIX) Says Clinical Hold Placed on IDX19368 by FDA

Aug 17, 2012 02:54 PM Barclays Lowers Outlook on Idenix Pharmaceuticals (IDIX); Clarity on FDA Clinical Hold (BMY, VRTX, GILD)

Aug 17, 2012 08:46 AM Leerink Swann maintains an 'Outperform' on Idenix Pharmaceuticals (IDIX); Clinical Hold Feels More Like Precaution

Aug 17, 2012 07:45 AM Jefferies Maintains a 'Hold' on Gilead Sciences (GILD); We Don't Believe

Aug 16, 2012 09:50 AM Idenix (IDIX) News Shakes-Up Hep C Sector (VRTX) (GILD) (BMY) (ACHN)

Aug 16, 2012 08:54 AM Gilead Sciences (GILD) On Watch on Idenix News

Aug 16, 2012 08:08 AM UPDATE: Idenix (IDIX) IDX184 Placed on Partial Clinical Hold After Serious Cardiac-Related Event

Jul 25, 2012 08:31 AM Idenix Pharma (IDIX) Reports IDX719 Gets FDA Fast Track Designation

Jun 19, 2012 04:09 PM Idenix Pharma (IDIX) Updates on Ongoing Phase IIb for IDX184 in Combo w/ PegIFN/RBV

Apr 19, 2012 09:21 AM Idenix Pharma (IDIX) Rips, Reports Encouraging Data from IDX719 Phase I

Feb 17, 2012 07:11 AM Gilead Sciences (GILD) Data Shakes-Up Hep-C Space (VRTX) (IDIX) (ACHN)

Feb 3, 2012 08:06 AM FDA Removes Partial Clinical Hold from Idenix Pharma's (IDIX) IDX184

Feb 3, 2012 08:04 AM Idenix (IDIX) announces removal of partial clinical hold on HCV nucleotide inhibitor, IDX184

Jan 9, 2012 07:08 AM Idenix Pharma (IDIX) Updates on HCV Treatment Pipeline; Initiates IDX719 Phase I

Jan 9, 2012 07:07 AM Idenix Pharma (DIX) Says IDX184 Demonstrated High Level of Resistance to In Vitro, Antiviral Acitivity

Dec 16, 2011 09:22 AM Vertex (VRTX) Higher After Pharmasset (VRUS) Hep-C Trial Issues

Dec 16, 2011 08:30 AM Watch Other Hep C Drug Makers on Pharmasset (VRUS) QUANTUM News: INHX IDIX ACHN

Feb 9, 2011 05:19 PM Idenix Pharma (IDIX) Updates on Three Developments; FDA Hold on IDX184 Removed

Nov 23, 2010 08:02 AM Idenix Pharma (IDIX) Receives $20M Milestone in GSK2248761 Development

Sep 7, 2010 07:42 AM Idenix Pharma (IDIX) Shares Resume Trading Down Almost 55%

Sep 7, 2010 07:16 AM Idenix Pharma (IDIX) Receives Clinical Hold from U.S. FDA for IDX184 and IDX320 Programs

Jul 26, 2010 04:11 PM Idenix Pharma (IDIX) Posts Q2 Loss of $0.23, Wider than Views; Updates on Hepatitis C Virus Programs

Jun 10, 2010 08:08 AM Idenix Pharma (IDIX) Initiates Concept Study for IDX320 in HCV Genotype-1 Infected Patients

Apr 16, 2010 06:59 AM Idenix Pharma (IDIX) Announces Positive IDX320 Phase I Data

Apr 15, 2010 06:53 AM Idenix Pharma (IDIX) To Present Data from IDX184 Phase IIa

Jan 11, 2010 07:59 AM Idenix Pharma (IDIX) Announces Progress in Three HCV Programs; Updates on FY09 Guidance

Feb 6, 2009 07:12 AM Idenix (IDIX) Enters License Agreement With GlaxoSmithKline For HIV Treatment IDX899

Jan 12, 2009 09:51 AM Idenix Pharmaceuticals (IDIX) Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)

Feb 6, 2008 05:36 PM Idenix (IDIX) Demonstrates Inhibition of HIV Replication in a Phase I/II Clinical Trial

Jul 13, 2007 08:59 AM Idenix Pharmaceuticals (IDIX) Says FDA Placed Clinical Hold on Valopicitabine Development Program

Jun 12, 2007 08:24 AM Idenix Pharmaceuticals (IDIX) Higher After Positive Phase II Study Results

Apr 30, 2007 09:09 AM Idenix Pharmaceuticals (IDIX) Higher on European Approval for SEBIVO

Apr 13, 2007 12:51 PM Idenix (IDIX) Said SEBIVO Demonstrated Better Antiviral Activity Compared to Adefovir

Apr 12, 2007 08:49 AM Idenix (IDIX) Reports Results from Two Phase IIb Studies of the Combination of Valopicitabine and Pegylated Interferon in Hepatitis C Genotype-1 Patients

Mar 1, 2007 04:36 PM Preclinical Data From Two Novel Idenix (IDIX) Compounds for the Treatment of HIV Presented at Conference

Oct 25, 2006 03:43 PM FDA Approves Idenix's (IDIX) TYZEKA for Chronic Hepatitis B

Mar 29, 2006 06:59 AM Idenix Pharma (IDIX) Said Novartis Exercised its Option to License Valopicitabine

Mar 27, 2006 08:37 AM Idenix (IDIX) and Novartis Said Telbivudine More Effective Than Lamivudine in China Study

Mar 24, 2006 12:39 AM Citigroup downgrades Idenix Pharma (IDIX) to Hold

Mar 23, 2006 05:28 PM Idenix (IDIX) Modifies Clinical Development of Valopicitabine for Hepatitis C

Jan 9, 2006 08:11 AM IDIX Reports Positive 4-Week Data

Jan 3, 2006 08:04 AM IDIX/NVS Submits NDA for Telbivudine

Dec 2, 2005 12:07 PM IDIX Update on Clinical Development Program for Valopicitabine After FDA Meeting

Back to IDIX Stock Lookup